The Prevalence and Distribution of Vitreoretinal Interface Abnormalities among Urban Community Population in China
Table 2
Characteristics for all subjects.
All participants
Type 2 diabetes patients
Normal subjects
value
Age, n (%)
608
304 (50.00)
304 (50.00)
45–54 years
193 (31.74)
95 (31.25)
98 (32.24)
0.93
55–64 years
212 (34.87)
108 (35.52)
104 (34.21)
≥65 years
203 (33.39)
101 (33.22)
102 (33.55)
Sex, n (%)
Females
340 (55.92)
172 (56.58)
168 (55.26)
0.74
Males
268 (44.08)
132 (43.42)
136 (44.74)
Duration of DM, n (%)
<5 years
125 (41.12)
125 (41.12)
N/A
N/A
6–15 years
101 (33.22)
101 (33.22)
N/A
≥16 years
78 (25.66)
78 (25.66)
N/A
Hypertension, n (%)
Absent
270 (30.87)
125 (41.12)
145 (47.69)
0.10
Present
338 (69.13)
179 (58.88)
159 (52.30)
FPG, mmol/L, mean ± SD
7.96 ± 2.43
9.23 ± 3.47
5.25 ± 1.08
<0.01
TG, mmol/L, mean ± SD
1.87 ± 0.45
1.99 ± 0.53
1.82 ± 0.34
<0.01
TC, mmol/L, mean ± SD
5.28 ± 1.68
5.79 ± 1.20
4.98 ± 1.45
<0.01
HbA1c, %
7.88 ± 1.05
10.11 ± 1.76
5.78 ± 0.83
<0.01
Fasting plasma glucose (FPG); glycosylated hemoglobin (HbA1c); triglyceride (TG); total cholesterol (TC). value showed difference between Type 2 diabetes patients and normal control groups.
